Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1989 May;27(5):849–853. doi: 10.1128/jcm.27.5.849-853.1989

Enzyme immunoassay for anti-hepatitis B core (HBc) immunoglobulin G1 and significance of low-level results in competitive assays for anti-HBc.

M Sällberg 1, L O Magnius 1
PMCID: PMC267442  PMID: 2663917

Abstract

An enzyme immunoassay (EIA) for anti-hepatitis B core (HBc) immunoglobulin G1 (IgG1) was compared with a commercial radioimmunoassay (RIA) for anti-HBc antibody (Corab: Abbott Laboratories, North Chicago, Ill.). In parallel tests of 445 consecutive samples, discrepant results were obtained with 2 samples, 1 of which was positive only by the RIA and the other of which was positive only by the EIA for anti-HBc IgG1. In tests of another 192 samples with low blocking activity in the RIA (inhibition range, 90 to 30%), 10 samples gave discrepant results, 5 of which were positive only by the RIA and the other 5 of which were positive only by the EIA for anti-HBc IgG1. Of 12 samples with discrepant results, 11 samples were tested further for anti-HBc IgG3, IgM, and IgA1 by the EIA. Of these, seven samples were positive for anti-HBc IgG1, anti-HBc IgG3, or both. All seven samples were also positive for anti-hepatitis B surface (HBs) antigen. Three samples were negative for anti-HBc IgG1, anti-HBc IgG3, or both but were positive for anti-HBc IgM, anti-HBc IgA1, or both; and one sample was reactive only in the RIA. These four samples were all negative for anti-HBs. Thus, low-level results in the RIA caused by anti-HBc IgM, anti-HBc IgA, or both reflect the unspecific activation of immature B lymphocytes that is not related to previous exposure to hepatitis B virus (HBV). In contrast, the presence of anti-HBc IgG1, anti-HBc IgG3, or both indicates differentiated anti-HBc IgG-producing plasma cells and previous exposure to HBV, as was also shown by the presence of anti-HBs. On class and subclass determination for confirmation of positivity for anti-HBc in 19 serum samples, which was identified by screening of blood from 1,343 donors by a competitive EIA (Hepanostika; Organon), 9 samples with positive results, all low level, did not indicate previous exposure to HBV. It was concluded that determination of classes and subclasses of anti-HBc provides a tool for discriminating positive anti-HBc results not caused by HBV exposure.

Full text

PDF
849

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aymard J. P., Janot G., Gayet S., Guillemin C., Canton P., Gaucher P., Streiff F. Post-transfusion non-A, non-B hepatitis after cardiac surgery. Prospective analysis of donor blood anti-HBc antibody as a predictive indicator of the occurrence of non-A, non-B hepatitis in recipients. Vox Sang. 1986;51(3):236–238. doi: 10.1111/j.1423-0410.1986.tb01961.x. [DOI] [PubMed] [Google Scholar]
  2. Bahna S. L., Heiner D. C., Horwitz C. A. Sequential changes of the five immunoglobulin classes and other responses in infectious mononucleosis. Int Arch Allergy Appl Immunol. 1984;74(1):1–8. doi: 10.1159/000233507. [DOI] [PubMed] [Google Scholar]
  3. Conley M. E., Bartelt M. S. In vitro regulation of IgA subclass synthesis. II. The source of IgA2 plasma cells. J Immunol. 1984 Nov;133(5):2312–2316. [PubMed] [Google Scholar]
  4. Draelos M., Morgan T., Schifman R. B., Sampliner R. E. Significance of isolated antibody to hepatitis B core antigen determined by immune response to hepatitis B vaccination. JAMA. 1987 Sep 4;258(9):1193–1195. [PubMed] [Google Scholar]
  5. Hadler S. C., Murphy B. L., Schable C. A., Heyward W. L., Francis D. P., Kane M. A. Epidemiological analysis of the significance of low-positive test results for antibody to hepatitis B surface and core antigens. J Clin Microbiol. 1984 Apr;19(4):521–525. doi: 10.1128/jcm.19.4.521-525.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hanson M. R., Polesky H. F. Evaluation of routine anti-HBc screening of volunteer blood donors: a questionable surrogate test for non-A, non-B hepatitis. Transfusion. 1987 Jan-Feb;27(1):107–108. doi: 10.1046/j.1537-2995.1987.27187121451.x. [DOI] [PubMed] [Google Scholar]
  7. Hawkes R. A., Boughton C. R., Ferguson V., Lehmann N. I. Use of immunoglobulin M antibody to hepatitis B core antigen in diagnosis of viral hepatitis. J Clin Microbiol. 1980 Jun;11(6):581–583. doi: 10.1128/jcm.11.6.581-583.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Kline W. E., Bowman R. J., McCurdy K. K., O'Malley J. P., Sandler S. G. Hepatitis B core antibody (anti-HBc) in blood donors in the United States: implications for surrogate testing programs. Transfusion. 1987 Jan-Feb;27(1):99–102. doi: 10.1046/j.1537-2995.1987.27187121486.x. [DOI] [PubMed] [Google Scholar]
  9. Koziol D. E., Holland P. V., Alling D. W., Melpolder J. C., Solomon R. E., Purcell R. H., Hudson L. M., Shoup F. J., Krakauer H., Alter H. J. Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood. Ann Intern Med. 1986 Apr;104(4):488–495. doi: 10.7326/0003-4819-104-4-488. [DOI] [PubMed] [Google Scholar]
  10. Lander J. J., Alter H. J., Purcell R. H. Frequency of antibody to hepatitis-associated antigen as measured by a new radioimmunoassay technique. J Immunol. 1971 May;106(5):1166–1171. [PubMed] [Google Scholar]
  11. Lee H. S., Rajagopalan M. S., Chien D., Cordell R., Perkins H. A., Vyas G. N. Specificity of enzyme immunoassay for hepatitis B core antibody used in screening blood donors. Transfusion. 1987 Jan-Feb;27(1):103–106. doi: 10.1046/j.1537-2995.1987.27187121450.x. [DOI] [PubMed] [Google Scholar]
  12. Linde A., Andersson J., Lundgren G., Wahren B. Subclass reactivity to Epstein-Barr virus capsid antigen in primary and reactivated EBV infections. J Med Virol. 1987 Feb;21(2):109–121. doi: 10.1002/jmv.1890210203. [DOI] [PubMed] [Google Scholar]
  13. Linde G. A. Subclass distribution of rubella virus-specific immunoglobulin G. J Clin Microbiol. 1985 Jan;21(1):117–121. doi: 10.1128/jcm.21.1.117-121.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Ling C. M., Overby L. R. Prevalence of hepatitis B virus antigen as revealed by direct radioimmune assay with 125 I-antibody. J Immunol. 1972 Oct;109(4):834–841. [PubMed] [Google Scholar]
  15. Milich D. R., McLachlan A. The nucleocapsid of hepatitis B virus is both a T-cell-independent and a T-cell-dependent antigen. Science. 1986 Dec 12;234(4782):1398–1401. doi: 10.1126/science.3491425. [DOI] [PubMed] [Google Scholar]
  16. Morell A., Roth-Wicky B., Skvaril F. Immunoglobulin G subclass restriction of antibodies against hepatitis B surface antigen. Infect Immun. 1983 Feb;39(2):565–568. doi: 10.1128/iai.39.2.565-568.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Skvaril F. IgG subclasses in viral infections. Monogr Allergy. 1986;19:134–143. [PubMed] [Google Scholar]
  18. Skvaril F., Joller-Jemelka H. IgG subclasses of anti-HBs antibodies in vaccinated and nonvaccinated individuals and in anti-HBs immunoglobulin preparations. Int Arch Allergy Appl Immunol. 1984;73(4):330–337. doi: 10.1159/000233493. [DOI] [PubMed] [Google Scholar]
  19. Stevens C. E., Aach R. D., Hollinger F. B., Mosley J. W., Szmuness W., Kahn R., Werch J., Edwards V. Hepatitis B virus antibody in blood donors and the occurrence of non-A, non-B hepatitis in transfusion recipients. An analysis of the Transfusion-Transmitted Viruses Study. Ann Intern Med. 1984 Dec;101(6):733–738. doi: 10.7326/0003-4819-101-6-733. [DOI] [PubMed] [Google Scholar]
  20. Sundqvist V. A., Linde A., Wahren B. Virus-specific immunoglobulin G subclasses in herpes simplex and varicella-zoster virus infections. J Clin Microbiol. 1984 Jul;20(1):94–98. doi: 10.1128/jcm.20.1.94-98.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Tedder R. S., Cameron C. H., Wilson-Croome R., Howell D. R., Colgrove A., Barbara J. A. Contrasting patterns and frequency of antibodies to the surface, core, and e antigens of hepatitis B virus in blood donors and in homosexual patients. J Med Virol. 1981;6(4):323–332. doi: 10.1002/jmv.1890060407. [DOI] [PubMed] [Google Scholar]
  22. Zuck T. F., Sherwood W. C., Bove J. R. A review of recent events related to surrogate testing of blood to prevent non-A, non-B posttransfusion hepatitis. Transfusion. 1987 Mar-Apr;27(2):203–206. doi: 10.1046/j.1537-2995.1987.27287150202.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES